Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Virtual Renality: Assessing the Impact of Virtual Reality on Preoperative Planning in Renal Cancer Surgery [NA]
This clinical trial update describes a study evaluating the impact of virtual reality on preoperative planning in renal cell carcinoma surge…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Autologous Dendritic Cell Vaccine in Kidney Cancer [Phase 2]
A Phase 2 trial evaluating an autologous dendritic cell vaccine for renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT
A completed clinical trial evaluating the use of FPIA PET/CT to measure treatment response in metastatic renal cell carcinoma.
-
CLINICAL_TRIALS withdrawal · 2025-05-02Clinical Trial Update: Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery [EARLY_Phase 1]
A clinical trial evaluating contrast-enhanced ultrasound to predict treatment response in renal cell carcinoma patients undergoing cryosurge…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
A clinical trial update describing a study to quantify systemic immunosuppression to personalize cancer therapy and that the trial is curren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005) [Phase 3]
Phase 3 trial comparing belzutifan to everolimus in advanced renal cell carcinoma; results have been posted.
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
A multicenter study is evaluating an 18F-labeled PET imaging agent (NY104) for renal cell carcinoma imaging, currently in recruitment.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition [Phase 2]
This Phase 2 clinical trial update describes cytoreductive surgery for kidney cancer combined with immunotherapy and targeted kinase inhibit…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC) [Phase 1]
Phase 1 study evaluating the combination of lenvatinib and everolimus in renal cell carcinoma has completed.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors [Phase 1]
Phase 1 trial update studying the immune effects of a fermented wheat germ extract added to standard checkpoint inhibitor therapy in patient…
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors [Phase 1]
Phase 1 study of TBio-6517 alone or in combination with pembrolizumab in solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Clinical Study of 18F -FAPI-RGD in Renal Tumor
The clinical study evaluating the imaging tracer 18F-FAPI-RGD for renal cell carcinoma has completed.
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: The Value of a Convolutional Neural Network-Based Renal Artery Perfusion Model in Predicting Renal Function After Partial Nephrectomy: A Prospective Study
This clinical trial evaluates whether a convolutional neural network-based renal artery perfusion model can predict renal function after par…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV) [Phase 3]
Phase 3 study assessing pazopanib with or without abexinostat in locally advanced or metastatic renal cell carcinoma; recruitment is ongoing…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma
A completed clinical trial update presenting results from a survey of cabozantinib use in patients with renal cell carcinoma.
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Analysis of Predictive Factors for Urinary Leakage After Partial Nephrectomy for Renal Hilum Tumors
This clinical trial update analyzes factors that may predict urinary leakage after partial nephrectomy in patients with renal hilum tumors.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN) [Phase 2]
Phase 2 AXIPAN trial of Axitinib for downstaging large renal tumors not suitable for partial nephrectomy has completed.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Prospective Study on the Safety and Efficacy of Robot-Assisted Laparoscopic Partial Nephrectomy With Renal Artery Off-Clamp in the Treatment of cT1 Renal Tumors [NA]
Prospective clinical trial evaluating the safety and efficacy of robot-assisted laparoscopic partial nephrectomy with renal artery off-clamp…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 open-label study evaluating Alomfilimab (KY1044) alone and with atezolizumab in multiple advanced cancers. The trial was terminate…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TT-10 and TT-4 (Portage Biotech) exploring single-agent and combination therapy in advanced solid tumors, with rec…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Planning Operative Strategy Using a Digital Renal Artery Clamping Tool [NA]
Clinical trial evaluating a digital renal artery clamping tool to plan operative strategy for renal cell carcinoma, with recruitment ongoing…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study) [Phase 3]
Completed Phase 3 trial evaluating robot-assisted partial nephrectomy with and without mixed reality guidance (REALITATEM Study) for renal c…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Empa PASS on Urinary Tract Malignancies
Completed post-authorization safety study (PASS) evaluating empagliflozin for urinary tract malignancies with results posted.
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)
A Japanese retrospective study (J-DART2) reports treatment outcomes for renal cell carcinoma patients treated with the combination of avelum…
-
EMA approval · 2025-03-28EMA Authorised: Nexavar (sorafenib) — Bayer AG
The EMA authorised Nexavar (sorafenib) for hepatocellular carcinoma and renal cell carcinoma. The decision date was 13 February 2025.